# The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer

> **NCT01797913** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 70 (actual)

## Conditions studied

- THE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine

## Key facts

- **NCT ID:** NCT01797913
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2015-02
- **Final completion:** —
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797913, "The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01797913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*